Malignant melanoma during treatment with fumaric acid esters - Coincidence or treatment-related?;Maligne melanome unter systemischer therapie mit fumarsäreestern - Zufall oder therapiefolge?

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 3, 2011, Pages 223-224

  Barth, Dietrich ^a   Simon, Jan C ^a   Wetzig, Tino ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Fumaric acid esters; Immunosuppression; Malignant melanoma; Psoriasis; Systemic therapy

Indexed keywords

CYCLOSPORIN A; ETRETIN; FUMADERM; IMMUNOMODULATING AGENT; METHOTREXATE; METHOXSALEN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MELANOMA; PSORIASIS; PUVA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; SYSTEMIC THERAPY;

EID: 79952207507     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07479.x     Document Type: Article

References (16)

1. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The Risk of Lymphoma in Patients with Psoriasis. J Invest Derm 2006; 126: 2194-2201. (Pubitemid 44413165)
2. Stern RS, Leibman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. J Natl Cancer Inst 1998; 90: 1278-84. (Pubitemid 28433472)
3. Stern RS: PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44(5): 755-61.
4. Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, Lewis D, Littlejohn G, Miller MH, Ryan PF, Jolley D. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008; 59: 794-9. (Pubitemid 351847561)
5. Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheum 2007; 34: 322-31.
6. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Derm 2003; 120: 211-6. (Pubitemid 36513069)
7. Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, Listing J, Zink A. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther. 2010 Jan 8; 12(1).
8. Mrowietz U, Rostami-Yazdi M, Neureither M, Reich K. 15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris. J Dtsch Dermatol Ges. 2009 Apr;7 Suppl 2: S3-16.
9. Reich K, Thaci D, Mrowietz U, Kamps A, Neureither M, Luger T. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). J Dtsch Dermatol Ges. 2009 Jul;7(7): 603-11.
10. Arzneimittelkommission der deutschen Ärzteschaft - Fall Nr. 148377 - Deutsches Ärzteblatt 2009, Jg. 106, Heft 47.
11. Loewe R, Valero T, Kremling S, Pratscher B, Kunstfeld R, Pehamberger H, Petzelbauer P. Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res 2006; 66(24): 11888-96. (Pubitemid 46094201)
12. Yamazoe Y, Tsubaki M, Matsuoka H, Satou T, Itoh T, Kusunoki T, Kidera Y, Tanimori Y, Shoji K, Nakamura H, Ogaki M, Nishiura S, Nishida S. Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells. Cell Biol Int 2009; 33(10): 1087-94.
13. Ueda Y, Richmond A. NF-kappaB activation in melanoma. Pigment Cell Res 2006; 19(2): 112-24.
14. Valero T, Steele S, Neumüller K, Bracher A, Niederleithner H, Pehamberger H, Petzelbauer P, Loewe R. Combination of Dacarbazine and Dimethylfumarate Efficiently Reduces Melanoma Lymph Node Metastasis. J Invest Derm 2009; Nov 26 [ahead of print].
15. Treumer F, Zhu K, Gläser R, Mrowietz U. Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells. J Invest Derm 2003; 121: 1383-1388. (Pubitemid 38005490)
16. Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, Hennekes HH, Asadullah K, Docke WD. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Derm 2007; 127(4): 835-45. (Pubitemid 46434667)